Shares of Moderna and Metagenomi, backed by Bayer, fell 32%

Shares of Metagenomi Technologies, a genetic drug company backed by Bayer Healthcare, opens a new tab and Moderna, opens a new tab, fell 32% during its debut on the Nasdaq. The stock opened for trading at $10.25, compared to its IPO price of $15 per share.

Share This Post: